At day 22, i took raltegravir from the box but im not sure whether i drank the pill with the water or not. Normally, I remember the pills that I drank through glass of water but i cannot remember this time whether i drank this pill with glass of water or not but i counted pills and i concluded that their numbers are as expected.
I searched couple of papers and i concluded not to double the dose in the case of i used that pill.
combining emtricitabine and tenofovir from the NRTI class, and raltegravir, from the integrase inhibitor class. There ARE alternative drugs available and possibly in Thailand they use lamivudine in place of raltegravir. I am definitely NOT a chemist, so I can't tell you for sure if the combination you're taking is appropriate. You should discuss your concerns with the doctor who prescribed PEP or a pharmacist/chemist. I wish you the best.
I started PEP 2 hrs later (truvada, norvir, raltegravir, and preszita), my initial results are negative. I do not know the viral load of the patient yet, i can only pray that it is low. I know odds are 0.3% but that doesnt settle my fears, i am young and want to live a happy healthy life with KIDS! DR. please tell me if you have honstly heard of any cases like mine that have converted. I am in awe and feel like my life is totally over and ruined.
I am currently taking truvada and isentress (raltegravir) is this enough I couldn't get my prescription for dolutegravir filled...is this pep enough?
I will know then if that is EOT or I go for 6 more weeks. The Merck trial presented wonderful results at the ASSLD conference. 97 out of 98 reached SVR. That was a 12 week study but did not include hard to treat such as null responders, cirrhotics and HIV. These new drugs are changing the way Hep C is treated---rapidly. The future looks bright for all of us. Still have a way to go, but I am optimistic about my trial and others.
Thu Apr 10, 2014 1:17am EDT (Reuters) - A two-drug combination being tested by Merck & Co to treat hepatitis C cured 98 percent of previously untreated patients without cirrhosis in a midstage clinical trial, providing the latest evidence that the U.S. drugmaker will be highly competitive in the fast evolving field.
Results of the study called C-Worthy were presented on Thursday at the annual meeting of the European Association for the Study of the Liver (EASL) in London.
m confused on the prescriptions given to me I have a 7 day dose of raltegravir and dolutegravir...thought it was supposed to be 28 days?
My treatment nurse set me up on the program with Pegassist
(Genentech Pegasys system): 1-888-941-3331
Peginterferon and Ribaviron
Commitment to Care (Merck PEG-Intron system): 1-866-363-6379, opt 1
Hope that helps.
I was paying $135 or so for Nasonex, which I thought was ridiculously expensive at the time. When Flonase became an OTC product, I thought Nasonex would become cheaper. That's what competition is supposed to do. But noooooo... I went to CVS today and the price was $218 for Nasonex. That is a total ripoff... Why did the price go up? So what's the difference between Merck, the manufacturer, and a robber with a gun on the street? Answer: The gun. Merck robs you without using a gun.
I appreciate your blunt response. I was prescribed Truvada + raltegravir (PEP) but could not obtain raltegravir in Europe. To be fair, I called the US PEP hotline who told me that I could take Truvada as PEP as there are no studies that prove it’s ineffective, so I didn’t start it without advice from the US HIV experts. I agree my anxiety is an issue but I legitimately was seeking an answer.
7 million to be paid by Merck. Before anyone feels bad for Merck, he or she should also know that some researchers estimate that Merck “earned” about $3 billion (with a “b”) in 2007 from Fosamax. There are still many unsettled suits.
While alendronate sodium does have some appropriate indications, there are serious side effects which can occur. Most of the lawsuits focus on one of two harms – femur fractures or osteonecrosis of the jaw.
The organization soon required that Merck updated the safety labeling to include this important risk information. Several other European health authorities also required Merck to make these safety label updates, including the United Kingdom’s Medical and Healthcare Products Regulatory Agency. However, Merck did not make the same safety label updates in the United States until the summer of 2011.
Recommended
